Related Experiment Video
Updated: Jan 2, 2026

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation
Published on: May 31, 2016
Mineral Bone Abnormalities and Vascular Calcifications
Matthew Ray1, Anna Jovanovich2
1Division of Renal Diseases and Hypertension, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO.
Insights
Vascular calcification (VC) is common in chronic kidney disease (CKD). Mineral bone abnormalities in CKD contribute to the development and progression of VC, increasing mortality risk.
Area of Science:
- Nephrology
- Cardiovascular Medicine
- Mineral Metabolism
Background:
- Vascular calcification (VC) is prevalent in chronic kidney disease (CKD), worsening with disease progression and strongly linked to mortality.
- VC involves hydroxyapatite crystal deposition in arteries, resembling bone formation.
- CKD disrupts mineral metabolism due to reduced glomerular filtration rate and altered levels of vitamin D, parathyroid hormone, and fibroblast growth factor 23.
Purpose of the Study:
- To review the role of mineral bone abnormalities in CKD-related vascular calcification.
- To explore the mechanisms linking disordered mineral metabolism to VC initiation and progression in kidney disease patients.
Main Methods:
- Review of cell culture studies.
- Analysis of animal models.
- Examination of observational and clinical studies.
Main Results:
- Abnormal mineral metabolism in CKD is implicated in VC.
- Dysregulation of calcium and phosphorus metabolism is a key factor.
- Evidence from multiple study types supports the link between mineral imbalances and VC.
Conclusions:
- Mineral bone abnormalities are significant contributors to vascular calcification in CKD.
- Understanding these mechanisms is crucial for managing VC in kidney disease.
- Targeting mineral metabolism may offer therapeutic strategies for VC.
Abstract:
Vascular calcification (VC) is common in chronic kidney disease, increases in prevalence as patients progress to end-stage renal disease, and is significantly associated with mortality. VC is a complex and highly regulated process similar to bone formation whereby hydroxyapatite crystals deposit in the intimal or medial layer of arteries. Mineral bone abnormalities are common in chronic kidney disease; reduction in glomerular filtration rate and changes in vitamin D, parathyroid hormone, and fibroblast growth factor 23 result in the dysregulation of phosphorus and calcium metabolism. Cell culture studies, animal models, and observational and clinical studies all suggest this abnormal mineral metabolism plays a role in the initiation and progression of VC in kidney disease. This review will focus on these mineral bone abnormalities and how they may contribute to mechanisms that induce VC in kidney disease.
Related Concept Videos
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Essential Minerals for Bone Health
Calcium and Phosphorus
Calcium is a critical component of bones, especially in the form of calcium phosphate and calcium carbonate. Since the body cannot make calcium, it must be obtained from the diet. However, calcium cannot be absorbed from the small intestine without...
Bone Remodeling
Imaging Studies for Cardiovascular System III: X-Ray
Definition and Purpose
An X-ray, or radiograph, is a non-invasive method that uses ionizing radiation to take images of internal structures. It is mainly used in cardiac imaging to examine the heart, lungs, and major blood vessels, aiming to identify abnormalities in the heart's size, shape, and position, such as heart failure, congenital defects, and vascular...
The Bone Matrix
Skeleton and Calcium Homeostasis

